O
OpenEvidence
AI-driven clinical decision support enhancing healthcare outcomes at the point of care
At a glance
- Founded
- 2022
- Headquarters
- Miami, United States
- Sector
- Health Tech & Medtech
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning OpenEvidence.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later12 investors entered at this stage
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
4 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where OpenEvidence was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
1 deals across OpenEvidence's capital deployment.
Where the deals concentrate by sector, stage, and decade.
OpenEvidence's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about OpenEvidence on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OpenEvidence on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.